MAPT and amyloidosis: A key limitation of this study is the reliance on the 3×Tg-AD mouse model, which, although useful for examining accelerated amyloidosis and tau deposition, does not recapitulate the full spectrum of Alzheimer’s disease pathogenesis in humans, particularly in sporadic cases.